| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Science Officer
1 company
David Aaron Kessler last filed a Form 4 in December 2024, as Chief Science Officer at RYM. David Aaron Kessler's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
David Aaron Kessler has 6 Form 4 filings on record from August 2022 to December 2024, all as Chief Science Officer at Rythm (RYM), 2022–2024.
The 18 reported transactions were 13 open-market sales, 4 option or other derivative awards and 1 option exercise.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $509K.
The only open-market sale was 13,598 shares of RYM at an average $37.44 on December 3, 2024, about $509K. Twelve months later RYM was down 39%.
Shares as reported in the last Form 4 for each company; the most recent is from December 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 3, 2024 | RYM Rythm, Inc. | Chief Science Officer | Sell | 13,598 | $37.44 | $509,094.13 | -100% | -43.9% | -39.4% |